Search research articles
Contact Us
Filters
Showing results (851-860 of 964) with videos related to
Page
of 97
Sort By:
Psychological Medicine
|
April 29, 2015
Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB)
A McCleery, M F Green, G S Hellemann, et al.
Scientific Reports
|
August 12, 2025
RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancer
Kyle C Strickland, Zachary D Wallen, Heidi C Ko, et al.
Schizophrenia Bulletin
|
August 26, 2006
Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop
Alan S Bellack, Michael F Green, Judith A Cook, et al.
Schizophrenia Research
|
July 27, 2019
MCCB cognitive profile in Spanish first episode schizophrenia patients
R Rodriguez-Jimenez, J L Santos, M Dompablo, et al.
Schizophrenia Bulletin
|
November 22, 2008
Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting
Deanna M Barch, Cameron S Carter, Amy Arnsten, et al.
Journal of Abnormal Psychology
|
February 10, 2010
Integrity of emotional and motivational states during the prodromal, first-episode, and chronic phases of schizophrenia
Cindy M Yee, Kristopher Ian Mathis, Jane C Sun, et al.
Schizophrenia Research
|
December 24, 2011
The MATRICS consensus cognitive battery (MCCB): co-norming and standardization in Spain
R Rodriguez-Jimenez, A Bagney, C Garcia-Navarro, et al.
Nature
|
February 24, 2012
Structure and dynamics of the M3 muscarinic acetylcholine receptor
Andrew C Kruse, Jianxin Hu, Albert C Pan, et al.
Nature
|
October 15, 2013
Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs
Ron O Dror, Hillary F Green, Celine Valant, et al.
The American Journal of Psychiatry
|
February 3, 2011
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia
Michael F Green, Nina R Schooler, Robert S Kern, et al.
Page
of 97
Search research articles
Search
Showing results (851-860 of 964) with videos related to
Sort By:
Page
of 97
Psychological Medicine
|
April 29, 2015
Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB)
A McCleery, M F Green, G S Hellemann, et al.
Scientific Reports
|
August 12, 2025
RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancer
Kyle C Strickland, Zachary D Wallen, Heidi C Ko, et al.
Schizophrenia Bulletin
|
August 26, 2006
Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop
Alan S Bellack, Michael F Green, Judith A Cook, et al.
Schizophrenia Research
|
July 27, 2019
MCCB cognitive profile in Spanish first episode schizophrenia patients
R Rodriguez-Jimenez, J L Santos, M Dompablo, et al.
Schizophrenia Bulletin
|
November 22, 2008
Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting
Deanna M Barch, Cameron S Carter, Amy Arnsten, et al.
Journal of Abnormal Psychology
|
February 10, 2010
Integrity of emotional and motivational states during the prodromal, first-episode, and chronic phases of schizophrenia
Cindy M Yee, Kristopher Ian Mathis, Jane C Sun, et al.
Schizophrenia Research
|
December 24, 2011
The MATRICS consensus cognitive battery (MCCB): co-norming and standardization in Spain
R Rodriguez-Jimenez, A Bagney, C Garcia-Navarro, et al.
Nature
|
February 24, 2012
Structure and dynamics of the M3 muscarinic acetylcholine receptor
Andrew C Kruse, Jianxin Hu, Albert C Pan, et al.
Nature
|
October 15, 2013
Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs
Ron O Dror, Hillary F Green, Celine Valant, et al.
The American Journal of Psychiatry
|
February 3, 2011
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia
Michael F Green, Nina R Schooler, Robert S Kern, et al.
Page
of 97